HPV and cervical cancer: screening or vaccination?

Bosch, F. X.; Castellsagué, X.; Sanjosé, S. de

HPV and cervical cancer: screening or vaccination?

Files

6604146a.pdf (196.23 KB)

Authors

Bosch, F. X.

Castellsagué, X.

Sanjosé, S. de

Issue Date

2008-01-08

Type

Article

Language

en_US

Keywords

Cervical Cancer , HPV Vaccines , HPV Screening

Abstract

Following the demonstration of the superior validity of human papillomavirus (HPV) tests in screening for cervical cancer and the arrival of highly efficacious HPV 16 and 18 vaccines, cervical cancer prevention enters a time of sustainable introduction in developing countries. Multidisciplinary efforts and novel protocols are being developed, and challenging situations are being faced to make cervical cancer, still the number two cancer in women worldwide, an eradicable condition.

Citation

Bosch, F. X., Castellsagué, X., & de Sanjosé, S. (2008). HPV and cervical cancer: screening or vaccination?. British journal of cancer, 98(1), 15–21. https://doi.org/10.1038/sj.bjc.6604146

Publisher

British Journal of Cancer